SUBSCRIBE: Print / eNewsletter
USPSTF Recommends Against Screening for Thyroid Cancer in Asymptomatic Adults
The US Preventive Services Task Force recently issued an updated statement recommending against screening for thyroid cancer in asymptomatic adults.
Younger Thyroid Cancer Survivors at Higher Risk for Late Effects
In this interview we discuss a study that found that survivors of thyroid cancer diagnosed with the disease at a young age had an increased risk of late effects from therapy.
RAS Mutation Presence in Thyroid Nodules Carried Risk for Cancer
Preoperative testing of thyroid nodules for RAS mutations showed that nodules that tested positive for HRAS and NRAS were associated with a substantial risk for cancer.
Age Associated with Papillary Thyroid Cancer Mortality
Patient age was found to be significantly associated with mortality from papillary thyroid cancer in a linear fashion with no apparent age cut point.
Lobectomy More Effective, Economical for Suspected Papillary Thyroid Cancer
Undergoing a lobectomy for thyroid nodules suspicious for papillary thyroid cancer on fine-needle aspiration was more cost effective and was associated with greater effectiveness compared with total thyroidectomy.
Pre-Op Assessment Could Help Define Thyroid Cancer Molecular Profile
Identifying certain characteristics of BRAF-positive and RAS-positive thyroid cancers may help define a molecular profile for the disease.
MSKCC Implementation of Active Surveillance for Thyroid Cancer
Memorial Sloan Kettering Cancer Center’s experience shows that selected patients with low-risk papillary thyroid cancer can safely defer surgery in favor of active surveillance.
I-131 for Thyroid Cancer Metastases
In this interview we discuss which distant metastases in thyroid cancer are appropriate targets for I-131 treatment, appropriate dosing, and more.
PI3K, HDAC Inhibition With CUDC-907 Shows Promise in Thyroid Cancer
Dual inhibition of PI3K signaling and histone deacetylase 2 (HDAC2) enzymes with CUDC-907 slowed thyroid tumor cell proliferation, tumor progression and metastasis, according to a preclinical study.
Immunotherapy Patients Should Be Monitored for Destructive Thyroiditis
The risk of immunotherapy-related destructive thyroiditis requires close patient monitoring and can cause permanent hypothyroidism.